The Healing Properties Of CBD

The relationship between infection and standard prescription antibiotics

Could CBD be useful in the battle against resistant bacterial pressures? The results from the University of Queensland in Australia recommend that it is possible. However prior to taking a look at the research study in depth, it is useful to comprehend the evolution of the relationship between germs and prescription antibiotics.

Given that the revolutionary discovery of penicillin by Alexander Fleming in 1928, prescription antibiotics have been an essential tool in the battle against germs and infections. And although we still use the very same tested methods today, germs have developed. When exposed to prescription antibiotics, specific germs, fungi and parasites are able to adapt and cancel the efficiency of the drug by establishing resistance.

It’s worth mentioning that antimicrobial resistance was likely to take place anyway, as the genetic code for germs modifications over time. Nevertheless, it is thought that the overuse of prescription antibiotics is a crucial element that speeds up the advancement of resistant pressures.

According to the World Health Organization, antimicrobial resistance “is a significantly serious threat to worldwide public health that requires action in all sectors of federal government and in society.” This has led researchers to believe outside package by attempting to determine substances that could be helpful in the battle against damaging germs. One of these substances is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Researchers are looking for brand-new methods to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works against Gram-positive germs. Strains of Gram-positive germs consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich presented his findings at an annual meeting of the American Society for Microbiology. In vitro samples of both kinds of gram-positive germs were treated with artificial CBD. The outcomes led Dr. Blaskovich to the conclusion that CBD operates at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also found that CBD appeared to work against gram-positive pressures of resistant germs, which many standard prescription antibiotics are starting to fail.

” In specific, the activity was picked against the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low tendency to cause resistance and was active against MRSA biofilms. “

The group also conducted another research study using topical CBD to treat a skin infection in mice. Again, although the outcomes were positive, CBD did not appear to get rid of the infection, however simply to decrease the number of bacterial cells.

Could CBD end up being an antibiotic?

While it is simple to hail this work as a substantial breakthrough in the anti-bacterial abilities of CBD, it is prematurely to give up on penicillin.

Although it is thought that the efficiency of CBD could come from the method it assaults the biofilm surrounding bacterial cells, the authors are still not sure of the system of action of CBD. They also did not think twice to point out the drawbacks of the research study. Dr. Blaskovich explained that considering that the outcomes are in the initial stages, it is far too early for individuals to start treating their CBD infections themselves.

The research study was also conducted in vitro (outside the body), and there is a threat that the outcomes of medical trials will not be the same. Numerous substances have shown anti-bacterial effectiveness in petri meals, however then stopped working at this crucial stage. It must also be mentioned that the two studies were carried out in collaboration with CBD Anything, a pharmaceutical business specializing in topical CBD products, such as those from CBD Rise.

Nevertheless, this research study could be a crucial step forward for CBD and the battle against antimicrobial resistance. CBD continues to have a great safety profile and is not considered hazardous even in large amounts. Thankfully, Dr. Blaskovich and his group plan to continue their research study.

Scroll to top